May 15, 2013 CHICAGO, May 15, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will be presenting at the 14th Annual B. Riley & Co. Investor Conference on May 20,... More
|
May 14, 2013 CHICAGO, May 14, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO - News), which manufactures and markets the FC2 Female Condom, today announced that it has named Andrew S. Love to... More
|
May 2, 2013 Diluted E.P.S. Increase 71% to $0.12, Versus $0.07 in Prior-Year Quarter CHICAGO, May 2, 2013 /PRNewswire/ -- Second Quarter Results: Unit sales increase 20% to 16.7 million units Net revenues rise 21% to $9.5 million Gross profit improves 21% to $5.5 million... More
|
Apr 25, 2013 Investor Conference Call Scheduled for 11:00 a.m. EDT CHICAGO, April 25, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the second... More
|
Mar 27, 2013 Company Also Plans to Increase Activity under Stock Repurchase Program CHICAGO, March 27, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), today announced that its Board of Directors has declared a quarterly cash dividend of $0.07 per share, which... More
|
Feb 20, 2013 CHICAGO, Feb. 20, 2013 /PRNewswire/ -- At the London Summit on Family Planning in July 2012, The Female Health Company (NASDAQ-CM: FHCO) announced a commitment to increase access to its FC2... More
|
Jan 30, 2013 Diluted E.P.S. Increase 33% to $0.12, Versus $0.09 in Prior-Year Quarter CHICAGO, Jan. 30, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), which manufactures and markets the FC2 Female Condom, today reported its financial results for the first quarter... More
|
Jan 23, 2013 Investor Conference Call Scheduled for 11:00 a.m. EST CHICAGO, Jan. 23, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the first... More
|
Jan 3, 2013 CHICAGO, Jan. 3, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share. The... More
|
Jan 2, 2013 CHICAGO, Jan. 2, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), which manufactures and markets the FC2 Female Condom®, today announced that O.B. Parrish, CEO, and Michele... More
|
Dec 4, 2012 FY2012 Diluted EPS Rise 179% to $0.53 vs. $0.19 in FY2011 CHICAGO, Dec. 4, 2012 /PRNewswire/ --The Female Health Company (NASDAQ-CM: FHCO), which manufactures and markets the FC2 Female Condom, today reported its financial results for the fourth quarter... More
|
Nov 27, 2012 Investor Conference Call Scheduled for 11:00 a.m. EST CHICAGO, Nov. 27, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the quarter... More
|
Nov 9, 2012 Michele Greco to Assume CFO Position on January 1, 2013 CHICAGO, Nov. 9, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), which manufactures and markets the FC2 Female Condom® (FC2), today announced that Donna Felch will retire from... More
|
Oct 30, 2012 CHICAGO, Oct. 30, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO), which manufactures and markets the FC2 Female Condom, today announced that it will be presenting at the... More
|
Oct 5, 2012 CHICAGO, Oct. 5, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO -FHCO - News), today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per... More
|
| |
